A Phase II Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia and Untreated CLL Patients With Genomic Deletion 11q
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 12 Jan 2021 Biomarkers information updated
- 16 Jan 2013 New trial record